In the brain, the major components of AD-associated amyloid plaques are Aβ1–40 peptides but also the more toxic Aβ1–42 species [7], characterized by two additional amino acids and generated through a sequential cleavage of the amyloid precursor protein (APP) by β and γ secretases [8]. The gene discussed is APP; the disease is Alzheimer disease.